StockWatch
·

SUN PHARMACEUTICAL INDUSTRIES LTD. Q3 FY25 Results

SUNPHARMAQ3 FY25 Results
Filing
MetricValue (₹ Cr)vs Q2 FY25
Revenue13.7K2.9%
Total Income14.1K3.6%
Expenditure10.3K3.0%
PBT3.5K3.4%
Net Profit2.9K4.1%
OPM17.03%2.15pp
NPM20.63%1.58pp
EPS12.104.7%
View full financials

Informational and educational content only. Not investment advice.